# Policosanol Blood Pressure Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/policosanol-blood-pressure-meta-analysis-evidence-review
Category: evidence-review
Summary: Policosanol Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass ar
Last reviewed: 2026-07-06
Reviewed by: Migaku Evidence Review
# Policosanol Blood Pressure Meta-analysis: What the Evidence Says

## Quick Answer

Policosanol Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 randomized trial.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Policosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double‐Blind, Multicenter Study | randomized trial | 2 | 2025-10-01 | 10.1111/jch.70126 |
| Efficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double‐Blind, Multicentre Study | randomized trial | 2 | 2025-04-06 | 10.1111/jch.14948 |

## What The Sources Report

- Hypertension is the most significant controllable risk factor for cardiovascular diseases, accounting for about 57% of all cardiovascular-related deaths. [Revueltas Aguero Moura (2025); evidence level 2]
- In addition, hypertension has been strongly associated with an increased risk of coronary heart disease, stroke, chronic kidney disease, and all-cause mortality. [Revueltas Aguero Moura (2025); evidence level 2]
- Hypertension is the most frequent modifiable cardiovascular risk factor, with more than 1 billion individuals living with high blood pressure worldwide. [Revueltas Moura (2025); evidence level 2]
- Evidence has proven the impact of lowering blood pressure for improving cardiovascular outcomes and all-cause mortality, making clear the relevance of promoting knowledge, prevention, and treatment of high blood pressure levels. [Revueltas Moura (2025); evidence level 2]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For policosanol blood pressure meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Revueltas Aguero Moura (2025). Policosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double‐Blind, Multicenter Study. DOI: 10.1111/jch.70126. PMCID: PMC12487964. PMID: 41032504. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open .... https://pmc.ncbi.nlm.nih.gov/articles/PMC12487964/
- Revueltas Moura (2025). Efficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double‐Blind, Multicentre Study. DOI: 10.1111/jch.14948. PMCID: PMC11973123. PMID: 40189869. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open .... https://pmc.ncbi.nlm.nih.gov/articles/PMC11973123/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.